{"SPADE_UN_11682": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11682", "Peptide Name": "RN7-IN7(designed based on indolicidin and ranalexin)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "FLGGLIKPWWPWRR", "Sequence Length": 14, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.26046345] Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=31.25μg/ml), Pseudomonas aeruginosa ATCC 15442(MIC=62.5μg/ml), Acinetobacter baumanii ATCC 15308(MIC=125μg/ml), citrobacter spp(MIC>250μg/ml), Klebsiella pneumoniae(MIC>250μg/ml) ;Gram-positive bacteria:Streptococcus pneumoniae(30 clinical isolates)(MIC=31.25-62.5μg/ml), Staphylococcus aureus ATCC 25923(MIC=31.25μg/ml), Methicillin resistant Staphylococcus aureus (MRSA)(MIC=31.25μg/ml), Enterococcus cloacae(MIC>250μg/ml),", "Hemolytic Activity": "[Ref.26046345] The hemolytic activities of RN7-IN7 is 0.0% at 15.62μg/ml against human RBCs.", "Cytotoxicity": "[Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 μg/ml. The cell viability of NL-20 is 95%, 92% and 6% at peptide concentrations of 62.5, 125 and 250 μg/ml.The cell viability of WRL-68 cell line is not affected(", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C92H130N24O15", "Mass": 1812.17, "PI": 12.0, "Net Charge": 3, "Hydrophobicity": -0.34, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Function": "Exhibits antimicrobial activity against the Gram-positive and Gram-negative bacteria.", "Literature": [{"Title": "Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.", "Pubmed ID": "26046345", "Reference": "PLoS One. 2015 Jun 5;10(6)e0128532.", "Author": "Jindal HM, Le CF, Mohd Yusof MY, Velayuthan RD, Lee VS, Zain SM, Isa DM, Sekaran SD.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26046345"}], "Frequent Amino Acids": "WGL", "Absent Amino Acids": "ACDEHMNOQSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 3, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11683", "Similarity": 1.0, "Sequence": "FLGGLIKKWPWWPWRR"}, {"SPADE_ID": "SPADE_UN_11700", "Similarity": 1.0, "Sequence": "FLGGLIKWWPWRR"}, {"SPADE_ID": "SPADE_UN_18453", "Similarity": 1.0, "Sequence": "YYGNGVYCTKNKCTVDWAKATTCIAGMSIGGFLGG"}]}}}